MDGL (Madrigal Pharmaceuticals) Days Inventory : 566.61 (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Madrigal Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Madrigal Pharmaceuticals's Average Total Inventories for the three months ended in Dec. 2024 was $21.4 Mil. Madrigal Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2024 was $3.4 Mil. Hence, Madrigal Pharmaceuticals's Days Inventory for the three months ended in Dec. 2024 was 566.61.

The historical rank and industry rank for Madrigal Pharmaceuticals's Days Inventory or its related term are showing as below:

MDGL' s Days Inventory Range Over the Past 10 Years
Min: 742.37 Med: 1995 Max: 1995
Current: 742.37

During the past 13 years, Madrigal Pharmaceuticals's highest Days Inventory was 1995.00. The lowest was 742.37. And the median was 1995.00.

MDGL's Days Inventory is ranked worse than
88.77% of 641 companies
in the Biotechnology industry
Industry Median: 178.94 vs MDGL: 742.37

Madrigal Pharmaceuticals's Days Inventory increased from Dec. 2023 (0.00) to Dec. 2024 (566.61). It might indicate that Madrigal Pharmaceuticals's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Madrigal Pharmaceuticals's Inventory Turnover for the three months ended in Dec. 2024 was 0.16.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Madrigal Pharmaceuticals's Inventory-to-Revenue for the three months ended in Dec. 2024 was 0.21.

Madrigal Pharmaceuticals Days Inventory Historical Data

The historical data trend for Madrigal Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Days Inventory Chart

Madrigal Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

1,995.00

Madrigal Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Inventory	Get a 7-Day Free Trial															-	-	568.59	334.70	566.61

Competitive Comparison of Madrigal Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, Madrigal Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's Days Inventory falls into.

Save Embed

;

Save Embed

;

Madrigal Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Madrigal Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0	+	34.068)	/	1 )	/	6.233	*	365
=	34.068					/	6.233	*	365
=	1,995.00

Madrigal Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (8.715	+	34.068)	/	2 )	/	3.445	*	365 / 4
=	21.3915					/	3.445	*	365 / 4
=	566.61

Madrigal Pharmaceuticals (NAS:MDGL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Madrigal Pharmaceuticals's Inventory Turnover for the three months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3.445	/	21.3915
	=	0.16

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Madrigal Pharmaceuticals's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	21.3915	/	103.32
	=	0.21

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Madrigal Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Madrigal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (NAS:MDGL) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

0JXI:UK YDO1:Germany YDO1:Germany

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

https://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Executives

Fred B Craves	director, 10 percent owner	750 BATTERY ST, STE 600, SAN FRANCISCO CA 94111
Robert E. Waltermire	officer: Senior VP, Chief Pharma Dev.	FOUR TOWER BRIDGE, 200 BARR HARBOR DRIVE, SUITE 200, WEST CONSHOHOCKEN PA 19428
James M Daly	director	INCYTE CORPORATION EXPERIMENTAL STATION, RTE 141 & HENRY CLAY RD. BLDG E336, WILMINGTON DE 19880
Kenneth Bate	director	C/O MILLENNIUM PHARMACEUTICALS INC, 40 LANDSDOWNE STREET, CAMBRIDGE MA 02139
William John Sibold	director, officer: President and CEO	C/O MADRIGAL PHARMACEUTICALS, INC., FOUR, TOWER BRIDGE, 200 BARR HARBOR DR STE 200, WEST CONSHOHOCKEN PA 19428
Rebecca Taub	director, officer: Chief Medical Officer, EVP R&D	750 BATTERY STREET, SUITE 330, SAN FRANCISCO CA 94111
Richard S Levy	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Paul A Friedman	director, officer: Chief Executive Officer	C/O INCYTE CORPORATION, 1801 AUGUSTINE CUT-OFF, WILMINGTON DE 19803
Baker Bros. Advisors Lp	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Brian Joseph Lynch	officer: SVP and General Counsel	480 MORRIS ROAD, BLUE BELL PA 19422
Felix Baker	director	BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014
Raymond Cheong	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
Julian Baker	director	BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014
Baker Brothers Life Sciences Lp	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014
L.p. 667,	director	860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014